A new study showed that taking menopausal hormone therapy comprising estrogen plus progestin for five years doubled a woman's risk of breast cancer, and suggested that the recent fall in breast cancer rates is predominantly due to a decrease in women having combined menopausal hormone therapy. The study was the work of lead investigator Dr.
More...